Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bundamedik Tbk (BMHS) vs Suparma Tbk. (SPMA) Price & Performance

Bundamedik TbkTrade
Suparma Tbk.Trade

Price performance (Past 24H)

Key statistics

Bundamedik Tbk vs Suparma Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 259.7K 24h volume), while Suparma Tbk. trades at Rp168 (market cap 688.85B, 409.7K 24h volume). The key difference: Bundamedik Tbk is far larger — about 2.2× Suparma Tbk.'s market cap, and Suparma Tbk. is more actively traded (409.7K versus 259.7K). Which is the better fit depends on your goals.

BMHSSPMA
Market Cap
1.51T688.85B
Volume
259.7K409.7K
Lot
2.6K4.1K
Turnover
45.69M68.4M
Average Price
175.91166.95
Value
45.69M68.4M
Indicative Equilibrium Price
177168
Indicative Equilibrium Volume
1085K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BMHS
View details
SPMA
View details

About Bundamedik Tbk

PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.

Read more on BMHS

About Suparma Tbk.

PT Suparma Tbk (Entity) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970 based on the Notarial Deed No. 29 of Tjahjadi Hartanto, S.H., on August 25, 1976. The Entity's name, PT Supar Inpama was changed to PT Suparma based in the Notarial Deed No. 5 dated December 7, 1978 of the same notary.

Read more on SPMA